In the realm of finance, ETFs (Exchange-Traded Funds) have emerged as essential tools for both casual and professional investors. Two of these ETFs, FXH and XLV, are frequently pitted against each other, mainly due to their focus on the healthcare sector. In this article, we delve deep into these two, breaking down their similarities, differences, and which might be more suitable for your portfolio.
Both FXH and XLV are heavily rooted in the healthcare sector, but their focus areas and top holdings differ.
FXH, known as the First Trust Health Care AlphaDEX Fund, uses a proprietary ranking system to select stocks from the Russell 1000 Index, which focuses on health care companies. Its method emphasizes growth and value factors. As a result, its holdings might lean towards companies showing promising growth or those perceived as undervalued.
On the other hand, XLV, the Health Care Select Sector SPDR Fund, tracks the Health Care Select Sector Index. This ETF comprises the healthcare stocks in the S&P 500. As such, its holdings predominantly include large-cap companies that are industry leaders. Giants like Johnson & Johnson, Pfizer, and Merck often feature as its top holdings.
FXH overlap FXH VS XLV
The capitalization strategy reveals another layer of differentiation between FXH and XLV.
FXH, with its AlphaDEX strategy, doesn't strictly follow market capitalization. Instead, it might give more weight to mid-cap stocks showing high potential in terms of value or growth. This strategy can offer more diversification and may have a higher return potential, but it also comes with increased volatility.
XLV primarily zeroes in on large-cap healthcare companies. The advantage? You're investing in established, stable firms with a long track record. However, the flip side is that these stocks may have slower growth compared to their mid-cap counterparts.
The manner in which these ETFs track the healthcare sector and the exposure they provide is another area of divergence.
FXH's AlphaDEX approach means it might not always closely track the broader healthcare sector's performance. However, it might outperform the sector when its selected stocks do well. Its method provides a more active management style, possibly leading to higher returns but also higher risks.
Conversely, XLV's strategy is more about tracking the healthcare sector's performance within the S&P 500 closely. An investor in XLV will likely experience returns (or losses) more in line with the broader healthcare market. It offers a more passive investment approach, which might appeal to those who prefer stability and fewer surprises.
Choosing between FXH and XLV boils down to your investment strategy, risk tolerance, and belief in the future of the healthcare sector. If you lean towards a more active strategy and believe in the potential of undervalued or high-growth stocks, FXH may appeal to you. If, however, you're more conservative and believe in the long-term stability of the big players in healthcare, XLV might be more your speed.
Either way, both ETFs offer a focus on a sector that is continually growing and innovating. As always, before making any investment decision, it's crucial to do your research, understand the risks involved, and maybe even consult with a financial advisor.
Note: Always ensure that you're following financial regulations and ethical guidelines when providing financial advice or insights."
FXH ETF issuer
FXH ETF official page
Discover the top holdings, correlations, and overlaps of ETFs using our visualization tool.
Our app allows you to build and track your portfolio.
To learn more about the XLV Health Care Select Sector SPDR Fund, access our dedicated page now.